Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases

CONCLUSION: Patients on treatment with TNFα inhibitors have better humoral response compared to the other b/tsDMARDs. However, when associated with methotrexate the seroprevalence decreases significantly.PMID:38418311 | DOI:10.1016/j.medcli.2023.12.011

Source: Medicina Clinica - February 28, 2024 Category: General Medicine Authors: Liz Romero-Bogado Martina Steiner Israel John Thuissard Vasallo Cristina Andreu V ázquez Teresa Nav ío Santiago Mu ñoz-Fernández de parte del grupo de estudio de f ármacos BIOlógicos en la infección por COVID (BIOCOVID) Source Type: research